STORY SUMMARY
Democrats say Trump increased investments in drugmakers that were given Medicare exemptions
The report from congressional Democrats found that Trump's pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to as much as $56.2 million at the end of 2025.
This is a brief summary of reporting from PBS NewsHour Headlines. Read the original for the full article and context.